ANNEX 3 Linies.pdf - FundaciÃ³ Institut d'InvestigaciÃ³ en CiÃ¨ncies de ...

More documents

Recommendations

Info

IF: 4,722 Maurel, J; Lopez-Pousa, A; de las Penas, R; Fra, J; Martin, J; Cruz, J; Casado, A; Poveda, A; Martinez-Trufero, J; Balana, C; Gomez, MA; Cubedo, R; Gallego, O; Rubio-Viqueira, B; Rubio, J; Andres, R; Sevilla, I; de la Cruz, JJ; del Muro, XG; Buesa, JM Efficacy of Sequential High-Dose Doxorubicin and Ifosfamide Compared With Standard-Dose Doxorubicin in Patients With Advanced Soft Tissue Sarcoma: An Open-Label Randomized Phase II Study of the Spanish Group for Research on Sarcomas J CLIN ONCOL 2009-APR 10; 27 (11): 1893-1898 IF: 17,793 Mellado, B; Font, A; Alcaraz, A; Aparicio, LA; Veiga, FJG; Areal, J; Gallardo, E; Hannaoui, N; Lorenzo, JRM; Sousa, A; Fernandez, PL; Gascon, P Phase II trial of short-term neoadjuvant docetaxel and complete androgen blockade in high-risk prostate cancer BRIT J CANCER 2009 oct-13;101:1248-1252 IF: 4,346 Millares, L; Rodriguez, N; Andreo, F; Sanz, J; Ramirez, JL; Lopez-Lisbona, R; Seto, L; Taron, M; Rosell, R; Monso, E; Rosell, A Aberrant promoter methylation in sputum and bronchial washing in patients at risk for lung cancer J THORAC ONCOL 2009-SEP; 4 (9): S635-S635 IF: 4,547 Mohammed, S; Syro, LV; Scheithauer, BW; Abad, A; Uribe, H; Rotondo, F; Horvath, E; Cusimano, M; Kovacs, K Pituitary Adenoma with Peliosis: A Report of Two Cases ENDOCR PATHOL 2009; 20:41-45 IF: 1,417 Moreno M, Sancho JM, Gardella S, Coll R, García O, Gallardo D, Ribera JM. Doxorubicina liposomal no pegilada en combinación con ciclofosfamida, vincristina, prednisona y rituximab en el tratamiento de linfomas no hodgkinianos: estudio de 26 pacientes. MED CLIN-BARCELONA 2009; Nov 11 IF: 1,231 Motlló C, Xicoy B, Sancho JM, Ribera JM. Infiltación cutánea masiva seguida de infiltración del sistema nervioso central en un paciente con leucemia mielomonocítica crónica. MED CLIN-BARCELONA 2009; JULIO IF: 1,231 Novello, S; Scagliotti, GV; Rosell, R; Socinski, MA; Brahmer, J; Atkins, J; Pallares, C; Burgess, R; Tye, L; Selaru, P; Wang, E; Chao, R; Govindan, R Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancer BRIT J CANCER 2009; 101:1543-1548 IF: 4,346 P Balsalobre, JL Diez-Martin, A Re, M Michieli, JM Ribera, C Canals, A Rosselet, E Conde, R Varela, K Cwynarski, I Gabriel,P Genet, G Guillerm, B Allione, A Ferrant, P Biron, I Espigado, D Serrano, A Sureda. The European experience on Autologous Stem Cell Transplantation in HIV-related lymphoma patients: An EBMT Lymphoma Working Party analysis. J CLIN ONCOL 2009; 27: 2192-2198. IF: 17,793 P Miralles, J Berenguer, JM Ribera. El diagnóstico, la profilaxis y el tratamiento de sistema nervioso central por el linfoma no Hodgkin en pacientes infectados por VIH MED CLIN-BARCELONA 2009; Jul 21 IF: 1,231 Paiva B, Vidriales MB, Mateo G, Pérez JJ, Montalbán MA, Sureda A, Montejano L, Gutiérrez NC, García de Coca A, de las Heras N, Mateos MV, López-Berges MC, García-Boyero R, Galende J, Hernández J, Palomera L, Carrera D, Martínez R, de la Rubia J, Martín A, González Y, Bladé J, Lahuerta JJ, Orfao A, San-Miguel JF; GEM (Grupo Español de MM)/PETHEMA (Programa para el Estudio de la Terapéutica en Hemopatías Malignas) Cooperative Study Groups. The persistence of immunophenotypically normal residual bone marrow plasma cells at diagnosis identifies a good prognostic Pàgina 36 de 67
subgroup of symptomatic multiple myeloma patients. BLOOD 2009;114(20):4369-72 IF: 10,555 Provencio, M; Camps, C; Alberola, V; Massutti, B; Vinolas, N; Isla, D; Domine, M; Millan, I; Cobo, M; Rosell, R Lung cancer and treatment in elderly patients: The Achilles Study LUNG CANCER 2009; 66:103-106 IF: 3,140 Provencio, M; Sanchez, A; Gasent, J; Gomez, P; Rosell, R Cancer Treatments: Can We Find Treasures at the Bottom of the Sea CLIN LUNG CANCER 2009; 10:295-300 IF: 1,509 Reguart, N; Isla, D; Cardenal, F; Cardona, A; Palmero, R; Moran, T; Rolfo, CD; Nadal, ES; Massuti, T; Montanes, A; Queralt, C; Taron, M; Rosell, R Phase I trial of vorinostat in combination with erlotinib for advanced non-small cell lung cancer (NSCLC) patients (pts) with EGFR mutations after erlotinib progression J THORAC ONCOL 2009-SEP; 4 (9): S708-S708 IF: 4,547 Rex J, Paradelo C, Mangas C, Hilari JM, Fernández-Figueras MT, Ferrándiz C Management of primary cutaneous Melanoma of the hands and feet: a clinicoprognostic study DERMATOL SURG 2009; 35(10):1505-13.(A) IF: 2,343 Ribera JM, Oriol A, Sancho JM, Morgades M, García O, Ferrá C, Xicoy B, Batlle M, Flores A, Vives S, Jiménez MJ, Juncà J, Granada I, Zamora L, Millá F, Feliu E. Tratamiento de la leucemia aguda linfoblástica del adulto. HAEMATOL-HEMATOL J 2009; 94 (extr 1): 39-50 IF: 6,416 Rodríguez I, Grau J, Sancho JM, Ribera JM. Síndrome hemofagocítico asociado a linfoma B difuso de célula grande. MED CLIN-BARCELONA 2009; DEC IF: 1,231 Rosell, R; Moran, T CLINICAL TRIALS BASED ON BIOMARKERS LUNG CANCER 2009-MAY; 64: S4-S4 IF: 3,140 Rosinol, L; Cibeira, MT; Martinez, J; Mateos, MV; Terol, MJ; de la Rubia, J; Palomera, L; de Arriba, F; Oriol, A; Amor, AA; Besalduch, J; de Paz, R; Garcia-Larana, J; Diaz-Mediavilla, J; Sureda, A; Lahuerta, JJ; San Miguel, J; Blade, J Thalidomide/Dexamethasone (TD) Versus Bortezomib (Velcade)/Thalidomide/Dexamethasone (VTD) Versus VB CLIN LYMPHOMA MYELOM 2009-FEB; 9 : S26-S26 IF: 1,130 Safont, MJ; Artal-Cortes, A; Sirera, R; Gomez-Codina, J; Gonzalez-Larriba, JL; Barneto, I; Carrato, A; Isla, D; Rosell, R; Camps, C Retrospective study of efficacy and toxicity on patients older than 70 years within a randomized clinical trial of two cisplatinbased combinations in patients with small-cell lung cancer LUNG CANCER 2009-JAN; 63 (1): 83-87 IF: 3,140 Sanchez-Wandelmer, J; Hernandez-Pinto, AM; Cano, S; Davalos, A; de la Pena, G; Puebla-Jimenez, L; Arilla-Ferreiro, E; Lasuncion, MA; Busto, R Effects of the antipsychotic drug haloperidol on the somastostatinergic system in SH-SY5Y neuroblastoma cells J NEUROCHEM 2009; 110:631-640 IF: 3,999 Sastre, J; Aranda, E; Massuti, B; Tabernero, J; Chaves, M; Abad, A; Carrato, A; Reina, JJ; Queralt, B; Gomez-Espana, A; Gonzalez- Flores, E; Rivera, F; Losa, F; Garcia, T; Sanchez-Rovira, P; Maestu, I; Diaz-Rubio, E Pàgina 37 de 67
Page 1 and 2: ANNEX 3 Relació detallada de la pr
Page 3 and 4: Pàgina 3 de 67
Page 5 and 6: Evolution of foamy macrophages in t
Page 7 and 8: J NUTR 2009-MAR; 139 (3): 603-610 I
Page 9 and 10: Sabariegos R, Picazo F, Domingo B,
Page 11 and 12: Carrascosa JM, Ferránidz C Tratami
Page 13 and 14: García-Casares E, Mateo L, García
Page 15 and 16: M Batlle, Quesada MD, Moreno M, JM
Page 17 and 18: ENFERM INFEC MICR CL 2009 Jan;27(1)
Page 19 and 20: Gonvers JJ, Froehlich F, Vader JP;
Page 21 and 22: JAIDS-J ACQ IMM DEF 2009 DEC 1;52:4
Page 23 and 24: J VIRAL HEPATITIS 2009; 16:513-518
Page 25 and 26: TOLERVIP-MS: inducció de tolerànc
Page 27 and 28: Caracterización y efectos de la in
Page 29 and 30: DOMINGUEZ BENITEZ, JOSE ANTONIO - M
Page 31 and 32: CÀNCER Publicacions INVESTIGACIÓ
Page 33 and 34: Alvarez, M; Lezcano, C; Ponton, JL;
Page 35: R Parody, J Pérez de Oteyza, E Bur
Page 39 and 40: IF: 5,673 Barba, I; Sanz, C; Barber
Page 41 and 42: Bio-ANITA project: increased BRCA1
Page 43 and 44: EPIDEMIOLOGIA CLÍNICA Y MOLECULAR
Page 45 and 46: HEPATOLOGY 2009, 50(supll):A875 IF:
Page 47 and 48: Vallès X, Murga GB, Hernández G,
Page 49 and 50: 2010). Durada: 3 anys - (2007-2010)
Page 51 and 52: H; Lehto, VP; Lundin, J A European
Page 53 and 54: IF: 1,694 Hernandez-Sabate, A; Gil,
Page 55 and 56: IF: 1,231 Ardèvol M, Valera M, Hid
Page 57 and 58: Cardona G, Bosch M, Costa J, Planas
Page 59 and 60: Garcia-Pagan, JC; Villanueva, C; Al
Page 61 and 62: Arch Soc Esp Oftalmol 2009 Mar;84(3
Page 63 and 64: Differences in Health Care of HIV-i
Page 65 and 66: INVESTIGACIÓ TRASLACIONAL Alvarez,
Page 67: (nadolol o carvedilol según respue

ANNEX 3 Linies.pdf - FundaciÃ³ Institut d'InvestigaciÃ³ en CiÃ¨ncies de ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?